The DEA Backs Down, Will Not Criminalize 5 Psychedelics
This week the DEA announced it would withdraw its plan to schedule 5 research psychedelics. But we shouldn’t celebrate just yet
This week the DEA announced it would withdraw its plan to schedule 5 research psychedelics. But we shouldn’t celebrate just yet
Does microdosing psychedelics work, or is it the placebo effect? Here are 3 microdosing clinical trials looking for answers
Tools for psychedelic sound therapy are becoming more popular. Here’s how you can use sound to enhance your psychedelic experience.
People around the world are learning about the mental health benefits of psychedelics. Here are 5 countries where psychedelics are legal.
As psychedelics continue to gain mainstream acceptance, these 5 states have started the process to legalize psychedelics
In today’s episode of PsycBiz, James —the Psychedelic Investor— sits…
In this episode, Christi provides insight into how ketamine impacts people’s physical and mental health. She goes into the comparison of ketamine’s effects compared to other psychedelics and how Flow Integrative’s patient care is unique.
There is growing interest in AI’s ability to mimic human interactions. We interview OpenAI’s GPT-3 chatbot to see what it knows about psychedelics.
Recent research suggests that mystical experiences may be one of the best predictors of positive outcomes in psychedelic therapy.
Alexander Shulgin was the greatest psychoactive chemist of the 20th century. James Kent recollects his visit to Shulgin’s lab in the final days before his passing.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.